Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sensitivity of three commercial tests for SARS-CoV-2 serology in children: an Italian multicentre prospective study.
Venturini E, Giometto S, Tamborino A, Becciolini L, Bosis S, Corsello G, Del Barba P, Garazzino S, Lo Vecchio A, Pugi A, Signa S, Stera G, Trapani S, Castelli Gattinara G, Lucenteforte E, Galli L. Venturini E, et al. Among authors: signa s. Ital J Pediatr. 2022 Dec 2;48(1):192. doi: 10.1186/s13052-022-01381-9. Ital J Pediatr. 2022. PMID: 36461032 Free PMC article.
Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles.
Saper VE, Ombrello MJ, Tremoulet AH, Montero-Martin G, Prahalad S, Canna S, Shimizu C, Deutsch G, Tan SY, Remmers EF, Monos D, Hahn T, Phadke OK, Cassidy E, Ferguson I, Mallajosyula V, Xu J, Rosa Duque JS, Chua GT, Ghosh D, Szymanski AM, Rubin D, Burns JC, Tian L, Fernandez-Vina MA, Mellins ED, Hollenbach JA; Drug Hypersensitivity Consortium; INCHARGE Consortium. Saper VE, et al. Ann Rheum Dis. 2022 Mar;81(3):406-415. doi: 10.1136/annrheumdis-2021-220578. Epub 2021 Nov 17. Ann Rheum Dis. 2022. PMID: 34789453 Free PMC article.
Type I interferon activation in RAS-associated autoimmune leukoproliferative disease (RALD).
Papa R, Rusmini M, Schena F, Traggiai E, Coccia MC, Caorsi R, Arrigo S, Pasetti F, Signa S, Barone P, Santamaria G, Spirito G, Sanges R, Vozzi D, Cavalli A, Gustincich S, Ravelli A, Gattorno M, Ceccherini I, Volpi S. Papa R, et al. Among authors: signa s. Clin Immunol. 2021 Oct;231:108837. doi: 10.1016/j.clim.2021.108837. Epub 2021 Aug 26. Clin Immunol. 2021. PMID: 34455097
International Prevalence and Mechanisms of SARS-CoV-2 in Childhood Arterial Ischemic Stroke During the COVID-19 Pandemic.
Beslow LA, Agner SC, Santoro JD, Ram D, Wilson JL, Harrar D, Appavu B, Fraser SM, Rossor T, Torres MD, Kossorotoff M, Zuñiga Zambrano YC, Hernández-Chávez M, Hassanein SMA, Zafeiriou D, Dowling MM, Kopyta I, Stence NV, Bernard TJ, Dlamini N; International Pediatric Stroke Study Group. Beslow LA, et al. Stroke. 2022 Aug;53(8):2497-2503. doi: 10.1161/STROKEAHA.121.038250. Epub 2022 Apr 5. Stroke. 2022. PMID: 35380052 Free PMC article.
Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment.
Bertoni A, Penco F, Mollica H, Bocca P, Prigione I, Corcione A, Cangelosi D, Schena F, Del Zotto G, Amaro A, Paladino N, Pontali E, Feasi M, Signa S, Bustaffa M, Caorsi R, Palmeri S, Contini P, De Palma R, Pfeffer U, Uva P, Rubartelli A, Gattorno M, Volpi S. Bertoni A, et al. Among authors: signa s. J Allergy Clin Immunol. 2022 Oct;150(4):796-805. doi: 10.1016/j.jaci.2022.05.029. Epub 2022 Jul 11. J Allergy Clin Immunol. 2022. PMID: 35835255 Free PMC article.
Recurrence of previous chilblain lesions during the second wave of COVID-19: can we still doubt the correlation with SARS-CoV-2?
Signa S, Sementa AR, Coccia MC, Pastorino C, Viglizzo G, Viola S, Volpi S, Occella C, Bleidl D, Acquila M, Castagnola E, Ravelli A, Manunza F. Signa S, et al. J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e475-e477. doi: 10.1111/jdv.17283. Epub 2021 May 1. J Eur Acad Dermatol Venereol. 2021. PMID: 33871076 Free PMC article. No abstract available.
Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality.
Lougaris V, Soresina A, Baronio M, Montin D, Martino S, Signa S, Volpi S, Zecca M, Marinoni M, Baselli LA, Dellepiane RM, Carrabba M, Fabio G, Putti MC, Cinetto F, Lunardi C, Gazzurelli L, Benvenuto A, Bertolini P, Conti F, Consolini R, Ricci S, Azzari C, Leonardi L, Duse M, Pulvirenti F, Milito C, Quinti I, Cancrini C, Finocchi A, Moschese V, Cirillo E, Crescenzi L, Spadaro G, Marasco C, Vacca A, Cardinale F, Martire B, Trizzino A, Licciardello M, Cossu F, Di Matteo G, Badolato R, Ferrari S, Giliani S, Pession A, Ugazio A, Pignata C, Plebani A. Lougaris V, et al. Among authors: signa s. J Allergy Clin Immunol. 2020 Aug;146(2):429-437. doi: 10.1016/j.jaci.2020.03.001. Epub 2020 Mar 10. J Allergy Clin Immunol. 2020. PMID: 32169379
Impact on rehabilitation programs during COVID-19 containment for children with pediatric and perinatal stroke.
Bertamino M, Cornaglia S, Zanetti A, Di Rocco A, Ronchetti A, Signa S, Severino M, Moretti P; Gaslini Stroke Study Group. Bertamino M, et al. Among authors: signa s. Eur J Phys Rehabil Med. 2020 Oct;56(5):692-694. doi: 10.23736/S1973-9087.20.06407-2. Epub 2020 Jun 9. Eur J Phys Rehabil Med. 2020. PMID: 32519529 Free article. No abstract available.
41 results